Vietnam Plasma Fractionation Market Updates 2024 : Market Dynamics, Key Strategies, Segments, and Competitive Scenario

WILMINGTON, DELAWARE , UNITED STATES, June 26, 2024 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, “Vietnam Plasma Fractionation Market by Product, Application, and End User: Opportunity Analysis and Industry Forecast, 2020–2027."

The Vietnam plasma fractionation market was valued at $56.62 million in 2019, and is expected to reach $79.03 million by 2027, registering a CAGR of 5.3% from 2020 to 2027.

The aging population and pre-existing medical issues among Vietnamese people as a result of the Second Indochina War are expected to fuel the market's expansion for Vietnam plasma fractionation. Furthermore, it is anticipated that the lack of alternatives to plasma fractionated products will propel market expansion in Vietnam, as these products are indestructible due to their histocompatibility, post-translational modifications, and lack of recombinant methods for protein replication. On the other hand, stricter laws that require products to meet higher quality standards as well as integrated logistics for locating and gathering blood plasma and ensuring prompt delivery to clinics, hospitals, and pharmacies are expected to impede market expansion.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/A06438

The market for plasma fractionation in Vietnam is divided into segments based on end user, product, and application. The market is divided into four product categories: coagulation factor VIII, coagulation factor IX, immunoglobulins, and albumin. The Vietnam plasma fractionation market is further divided into two segments: intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) under the immunoglobulin sector. The market is divided into critical care, immunology, hematology, neurology, and other categories based on application. The Vietnam plasma fractionation market is divided into two segments based on the end user: clinical research laboratories and hospitals.

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲
Based on product, the immunoglobulin segment was the highest contributor in 2019, growing at a CAGR of 5.6% during the forecast period.

Based on application, the neurology segment was the largest contributor in 2019, and is expected to grow at a CAGR of 5.9%.

On the basis of end user, the hospital segment is likely to dominate the Vietnam plasma fractionation market in the forecast year.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐅𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬
This report provides a detailed quantitative analysis of the current Vietnam plasma fractionation market trends and forecast estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.

An in-depth Vietnam plasma fractionation market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.

A comprehensive analysis of factors that drive and restrain the growth of the global is provided.

The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2027, in terms of value.

An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

Key market players within the Vietnam plasma fractionation market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the market.

𝐃𝐨 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠- https://www.alliedmarketresearch.com/purchase-enquiry/A06438

Leading market players analyzed in the research includes
Biotest AG
Baxter International Inc.
Getz Healthcare
Bio Products Laboratory Ltd.
Kedrion Biopharma
Grifols SA
Novo Nordisk
Octapharma
Sanquin Blood Supply Foundation
Sanova Healthcare

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐋𝐒 𝐃𝐨𝐦𝐚𝐢𝐧
𝐇𝐮𝐧𝐭𝐢𝐧𝐠𝐭𝐨𝐧’𝐬 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/huntington%E2%80%99s-disease-treatment-market-A17522
𝐒𝐚𝐫𝐜𝐨𝐩𝐞𝐧𝐢𝐚 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/sarcopenia-treatment-market-A10526

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X